A team of researchers from Kaunas University of Technology and Lithuanian University of Health Sciences proposed a non-invasive method for detection of melanoma. A patented computer-aided diagnostic system developed by Lithuanian scientists proved to be more than 90% accurate in detecting malignancy in diagnostic images of skin lesions acquired from 100 patients.
In Europe, melanoma is the fifth most common type of cancer and is the major cause of death from skin cancer. Northern Europe displays the largest age-standardised rate mortality of 3.8 per 10,000 in the region, with an incidence of 23.4.
Excision of a primary tumour remains essential in diagnosing melanoma, and the decision for the operation is generally based on the dermatoscopic evaluation of the lesion. However, the accuracy of melanoma clinical diagnosis is only at 65% and strongly relies on the experience of the physician-dermatologist carrying out the analysis.
“The novelty of our method is that it combines diagnostic information obtained from different non-invasive imaging technologies such as optical spectrophotometry and ultrasound. Based on the results of our research, we can confirm that the developed automated system can complement the non-invasive diagnostic methods currently applied in the medical practice by efficiently differentiating melanoma from a melanocytic mole”, says Professor Renaldas Raišutis, head of the team behind the research at Kaunas University of Technology.
In the study, carried out by the researchers of two Lithuanian universities, diagnostic images of skin lesions acquired from 100 different patients were evaluated. By comparing and analysing complex data on skin tumours recorded by different techniques, the researchers were able to develop a novel diagnostic system, differentiating melanoma from a benign nevus with accuracy higher than 90%.
“An efficient diagnosis of an early-stage malignant skin tumour could save critical time: more patients could be examined and more of them could be saved”, says Prof Raišutis.
According to Prof Raišutis, the novel diagnostic system is firstly aimed at medical professionals; he estimates that the price of the final product might be affordable even for smaller medical institutions. However, the team is also thinking about the solutions for individual use at home.
Following the research, the prototype of the technology was developed, and the clinical research is being carried out complying with the requirements of the protocol for the clinical research confirmed by the regional bioethics committee.
The invention was patented in Lithuania (Patent No. LT6670B) and the patent applications filed for Patent Cooperation Treaty and the United States Patent and Trademark Office.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Melanoma detection
- Can frequent ejaculation reduce the risk of prostate cancer?
Several studies over the past few years have reported that ejaculation can reduce prostate cancer by decreasing the concentration of toxins and crystal-like structures that can accumulate in the prost ...
- Dozens attend prostate cancer early detection event in Isle of Wight Co.
Men packed a community room in a Rushmere-area church on Saturday to learn about prostate cancer before getting screened.
- Firefighters get free skin cancer screenings at Smilow
As is the case with many cancers, early detection is the key to successfully treating melanoma, which typically appears as a new mole or a mole that has changed in size, shape or color, and needs to ...
- Chinese AI innovation identifies oesophageal cancer lesions at double rate of doctors’ assessment by eye: paper
Algorithm that highlights lesions on the gullet for doctors during an endoscopy is now used in hundreds of hospitals in China Early detection is key as the cancer has five-year survival rate of more ...
- Dr. Kyri Mosley Had Stage 4 Cancer. Now She’s Building A Cookie Empire
And she is not alone considering there are millions of people who have had cancer. But everyone’s experiences, stories, and paths to healing are different. For Dr. Mosley, exploring her passion for ...
Go deeper with Google Headlines on:
Melanoma detection
[google_news title=”” keyword=”melanoma detection” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Melanoma
- Man receives world’s first melanoma vaccine — trial underway
A trial for the world’s first-ever mRNA cancer vaccine for melanoma is underway in the UK. Melanoma is the deadliest form of skin cancer. Around 100,000 Americans are expected to be diagnosed with melanoma in 2024, according to the American Cancer Society.
- Melanoma is preventable, but is on the rise in UK - symptoms to know
Melanoma - skin cancer - the fifth most common cancer in the UK and experts are concerned about ever-increasing rates, even though 80% of cases are preventable
Go deeper with Google Headlines on:
Melanoma
[google_news title=”” keyword=”melanoma” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]